Acer Medical, a subsidiary of Acer, announced yesterday (6th) that its artificial intelligence (AI) healthcare software solutions have been successfully implemented in more than 500 medical institutions worldwide, including clinics, major hospitals, and diagnostic centers. The deployments span across Taiwan, Japan, Southeast Asia, Central America, and Europe, marking a significant milestone that highlights Acer Medical’s expertise in advancing AI applications for clinical decision support and early disease screening, as well as the strong global demand for smart healthcare solutions.

Acer Medical emphasized its commitment to developing practical AI-driven healthcare software. Its portfolio includes VeriSee DR, an AI-assisted diabetic retinopathy diagnostic tool; VeriSee AMD, an AI-assisted age-related macular degeneration screening tool; and VeriOsteo OP, an AI-assisted osteoporosis screening solution. All have received regulatory approvals in multiple countries and are designed to help healthcare providers improve diagnostic efficiency, reduce clinical workloads, and accelerate decision-making processes. Each solution can be seamlessly customized and integrated into existing hospital systems, while also supporting mobile device operations, thereby enhancing accessibility and flexibility.

Looking ahead, Acer Medical stated that it will continue to expand AI applications in healthcare, including gait and activity pattern analysis, behavioral risk assessment, and personalized health recommendations. These innovations aim to support elder care, chronic disease management, and home health monitoring. By strengthening cross-disciplinary technology integration and international market strategies, Acer Medical seeks to position itself as an innovation engine driving human health and well-being.

According to market research, the global AI healthcare market is expected to grow at an average annual rate of over 30% through 2030. Acer Medical noted that it will continue to invest in product development, data quality enhancement, and medical compliance, with the goal of becoming a key force in advancing smart healthcare across Asia and worldwide.

Resource: 宏碁智醫AI醫療軟體報捷 導入全球逾500間醫療院所